PharmGen Science, Inc. (004720) Stock Statistics & Valuation Metrics

PharmGen Science, Inc. has a market cap or net worth of ₩72.36B. The enterprise value is ₩45.24K.

PharmGen Science, Inc. has 22,654,366 shares outstanding. The number of shares has decreased by -2.65% in one year.

PharmGen Science, Inc.’s return on equity (ROE) is -0.80 and return on invested capital (ROIC) is 2.76%.

The current PE Ratio of PharmGen Science, Inc. is ―. PharmGen Science, Inc.’s PEG ratio is 0.00022.

In the last 12 months, PharmGen Science, Inc. had revenue of 173.07B and earned -116.64B in profits. Earnings per share was -5.31K.

In the last 12 months, operating cash flow was 17.33B and capital expenditures -2.39B, giving a free cash flow of 14.94B billion.

PharmGen Science, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

PharmGen Science, Inc. upcoming earnings date is Nov 18, 2026, TBA (Confirmed).

PharmGen Science, Inc. as a current ratio of 2.85, with Debt / Equity ratio of 0.50%

In the past 12 months, PharmGen Science, Inc. has paid -34.46B in taxes.

PharmGen Science, Inc. EV to EBITDA ratio is 7.15, with an EV/FCF ratio of 19.53.

PharmGen Science, Inc. has ₩20.05B in cash and marketable securities with ₩698.13M in debt, giving a net cash position of ₩19.35B billion.

Gross margin is 64.26%, with operating margin of 3.46%, and net profit margin of -67.39%.

The average price target for PharmGen Science, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―